DNA Microarray Activities
Activity 1: Making your slide
You have a sheet with 15 different DNA sequences that are available.
Activity 2: Using your DNA microarray
Get together with two or three other people. You will pool your DNA microchips for the next set of directions.
Each group should take a pair of envelopes of mRNA transcripts from the front table. Each is labeled with the cell type.
Type of cell |
Did you find RNA transcripts that matched your DNA microchip? |
How many transcripts were in the cell type? |
|
|
|
|
|
|
What can you conclude from your data?
Activity 2: Analyzing DNA microarray results
|
Gene 1 |
Gene 2 |
Gene 3 |
Gene 4 |
Gene 5 |
Gene 6 |
Gene 7 |
Gene 8 |
Gene 9 |
Gene 10 |
Chip |
Person 1 |
|
|
|
|
|
|
|
|
|
|
1 |
Person 2 |
|
|
|
|
|
|
|
|
|
|
2 |
Person 3 |
|
|
|
|
|
|
|
|
|
|
3 |
Person 4 |
|
|
|
|
|
|
|
|
|
|
4 |
Person 5 |
|
|
|
|
|
|
|
|
|
|
5 |
Additional Analysis
Homework:
A patient with cancer has the following gene expression (X means gene is ON).
Gene # 1 2 3 4 5 6 7 8 9 10
X X X X X X
This patient’s cancer responds very well to Gleevec, a drug recently approved by the FDA for the treatment of chronic myeloid leukemia, a rare type of leukemia. The drug has lower side effects and toxicity compared to standard cancer chemotherapy. Doctors are therefore wondering which other types of cancers would respond well to treatment with Gleevec. Rather than randomly testing the drug on other types of cancers, the doctors have decided to use DNA microarray experiments to predict which cancers are more likely to be susceptible to the drug.
The doctors test the tumors of five cancer patients and find the following results
|
Gene 1 |
Gene 2 |
Gene 3 |
Gene 4 |
Gene 5 |
Gene 6 |
Gene 7 |
Gene 8 |
Gene 9 |
Gene 10 |
Person 1 |
X |
|
X |
|
|
X |
|
X |
|
X |
Person 2 |
X |
X |
|
X |
X |
X |
|
X |
X |
X |
Person 3 |
|
|
|
X |
X |
|
X |
|
|
X |
Person 4 |
X |
X |
|
X |
X |
X |
|
X |
X |
|
Person 5 |
X |
X |
|
X |
|
X |
|
X |
X |
|
1. Can you tell from these preliminary results which type of cancer would be most likely to respond to Gleevec?
2. Are the results clear enough?
3. How would you improve the accuracy of your predictions?
4. As a physician, would you conclude with confidence which patient may be responsive to Gleevec?
5. Which patients, if any, would you treat with Gleevec?